Literature DB >> 18329

Drug-induced cardiovascular diseases.

S M Deglin, J M Deglin, E K Chung.   

Abstract

A wide variety of drugs may be associated with serious cardiovascular toxicity. Toxicity due to drugs primarily used for treating cardiovascular toxicity. Toxicity due to drugs primarily used for treating cardiac disorders is the most extensively documented, especially the arrhythmias due to digitalis glycosides. Various arrhythmias are also caused by toxic levels of many antiarrhythmic agents including quinidine, procainamide and phenytotin. Myocardial depression and heart failure are serious side-effects of beta-adrenoceptor blocking agents and myocardial ischaemia due to sympathominetic amines may result from both direct and indirect mechanisms. The many toxic reactions in the cardiovascular system due to non-cardiac drugs are less widely known and for the most part less clearly understood. Many remain controversial at the current time; for example, the diathesis toward thromboembolism in women taking oral contraceptives. Potential cardiac toxicity due to drugs used in the rapidly expanding sphere of anti-neoplastic chemotherapy is exemplified by the cardiomyopathy-like toxicities of doxorubicin and daunorubicin. Many of the psychotherapeutic drugs including phenothiazine antipsychotics and tricyclic antidepressants have arrhythmogenic potential.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 18329     DOI: 10.2165/00003495-197714010-00002

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  59 in total

1.  Angina-like syndrome with diazoxide therapy for hypertensive crisis.

Authors:  S A Kanada; D J Kanada; R A Hutchinson; D Wu
Journal:  Ann Intern Med       Date:  1976-06       Impact factor: 25.391

2.  Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs.

Authors:  N O Fowler; D McCall; T C Chou; J C Holmes; I B Hanenson
Journal:  Am J Cardiol       Date:  1976-02       Impact factor: 2.778

Review 3.  Cardiovascular injury induced by sympathetic catecholamines.

Authors:  J I Haft
Journal:  Prog Cardiovasc Dis       Date:  1974 Jul-Aug       Impact factor: 8.194

4.  Thromboembolism and oestrogen therapy.

Authors:  J C Bailar
Journal:  Lancet       Date:  1967-09-09       Impact factor: 79.321

5.  The effect of heroin and multiple drug abuse on the electrocardiogram.

Authors:  J Lipski; B Stimmel; E Donoso
Journal:  Am Heart J       Date:  1973-11       Impact factor: 4.749

Review 6.  Cardiac toxicity and psychotropic drugs.

Authors:  G E Crane
Journal:  Dis Nerv Syst       Date:  1970-08

7.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

Review 8.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

9.  Investigation of deaths from pulmonary, coronary, and cerebral thrombosis and embolism in women of child-bearing age.

Authors:  W H Inman; M P Vessey
Journal:  Br Med J       Date:  1968-04-27

10.  Endomyocardial fibrosis associated with daunorubicin therapy.

Authors:  R G Wilcox; P D James; P J Toghill
Journal:  Br Heart J       Date:  1976-08
View more
  5 in total

1.  New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria.

Authors:  Lisa H Xie; Qigui Li; Ai J Lin; Kirsten Smith; Jing Zhang; Donald S Skillman
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Sympathetic overactivity in tetanus: fatality associated with propranolol.

Authors:  N Buchanan; L Smit; R D Cane; M De Andrade
Journal:  Br Med J       Date:  1978-07-22

3.  Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication.

Authors:  P J Neuvonen; E Elonen; T Vuorenmaa; M Laakso
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

Review 4.  Heart and mind: (2) psychotropic and cardiovascular therapeutics.

Authors:  S U Shah; Z Iqbal; A White; S White
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

5.  Myocardial metabolism for the toxicologist.

Authors:  R G Merin
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.